# PT027 Compared to PT007 in Patients With Asthma With Mannitol-induced Acute Airway Obstruction

> **NCT05555290** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 190 (actual)

## Conditions studied

- Asthma

## Interventions

- **COMBINATION_PRODUCT:** PT027
- **COMBINATION_PRODUCT:** PT007

## Key facts

- **NCT ID:** NCT05555290
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-28
- **Primary completion:** 2024-11-18
- **Final completion:** 2024-11-18
- **Target enrollment:** 190 (ACTUAL)
- **Last updated:** 2026-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05555290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05555290, "PT027 Compared to PT007 in Patients With Asthma With Mannitol-induced Acute Airway Obstruction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05555290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*